Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03307850 · ClinicalTrials.gov registry record · NA
Impact of Non-glucose Signals on Glycemic Control in Patients With Type 1 Diabetes
A NA study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03307850 is a NA study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT03307850, a NA study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This clinical trial will identify exercise-related and emotional stress related effects on glycemic control in patients with type 1 diabetes using sensor-augmented pump (SAP) therapy.
Interventions
- OTHER Observation During Exercise and Stress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03307850
The ClinicalTrials.gov registry entry for NCT03307850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation During Exercise and Stress is the first listed.
NCT03307850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03307850 about?
NCT03307850 is a clinical study titled "Impact of Non-glucose Signals on Glycemic Control in Patients With Type 1 Diabetes". This clinical trial will identify exercise-related and emotional stress related effects on glycemic control in patients with type 1 diabetes using sensor-augmented pump (SAP) therapy.
What is the current status of trial NCT03307850?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-11-01. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT03307850?
The interventions under investigation include: Observation During Exercise and Stress (OTHER).
Who is sponsoring clinical trial NCT03307850?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.